HR 8630 · in committee · major
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.

Sponsor · R-OH-6
Michael A. Rulli
Citizen cosponsors
0
In Congress
1/ 435
House Reps cosponsoring
Introduced 2026-04-30
Joining the bill
Legislative timeline
2026-04-30 · house · IntroReferral
Referred to the House Committee on Energy and Commerce.
2026-04-30 · IntroReferral
Introduced in House
2026-04-30 · IntroReferral
Introduced in House

Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.